Shenzhen Ma'ermo Technology Co.,Ltd. – Trademark Portfolio

Entity Type: 99

Shenzhen Ma'ermo Technology Co.,Ltd. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 13 (Firearms) — 3 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include VIXROS and TACFLAME. The owner is based in LongHua Dist.,Shenzhen.

Rm.B831-1,8/F,TianhuiBldg.,Donghuan1stRd

Fukang Community, Longhua Street

LongHua Dist.,Shenzhen 518110 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

VIXROS
VIXROS
Registered 2022
TACFLAME
TACFLAME
Registered 2021
MLOK
MLOK
Abandoned 2020

Trademark Classifications

Shenzhen Ma'ermo Technology Co.,Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

13
Firearms (3 filings)

Firearms; ammunition and projectiles; explosives; fireworks

Frequently Asked Questions

How many trademarks does Shenzhen Ma'ermo Technology Co.,Ltd. have?

Shenzhen Ma'ermo Technology Co.,Ltd. has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Shenzhen Ma'ermo Technology Co.,Ltd. file in?

Shenzhen Ma'ermo Technology Co.,Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 13 (Firearms). Class 13 covers firearms; ammunition and projectiles; explosives; fireworks.

What are Shenzhen Ma'ermo Technology Co.,Ltd.'s most well-known trademarks?

Shenzhen Ma'ermo Technology Co.,Ltd.'s registered trademark portfolio includes well-known marks such as VIXROS and TACFLAME. These are among 2 currently registered trademarks in the portfolio.

What is Shenzhen Ma'ermo Technology Co.,Ltd.'s trademark registration success rate?

Shenzhen Ma'ermo Technology Co.,Ltd. has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.